Cargando…

ATM haplotypes and breast cancer risk in Jewish high-risk women

While genetic factors clearly play a role in conferring breast cancer risk, the contribution of ATM gene mutations to breast cancer is still unsettled. To shed light on this issue, ATM haplotypes were constructed using eight SNPs spanning the ATM gene region (142 kb) in ethnically diverse non-Ashken...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koren, M, Kimmel, G, Ben-Asher, E, Gal, I, Papa, M Z, Beckmann, J S, Lancet, D, Shamir, R, Friedman, E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361267/ https://www.ncbi.nlm.nih.gov/pubmed/16622469 http://dx.doi.org/10.1038/sj.bjc.6603062

Ejemplares similares

The R72P P53 mutation is associated with familial breast cancer in Jewish women
por: Ohayon, T, et al.
Publicado: (2005)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours
por: Marian, C, et al.
Publicado: (2005)

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
por: Lindmark, F, et al.
Publicado: (2005)

Mitochondrial and Y chromosome haplotype motifs as diagnostic markers of Jewish ancestry: a reconsideration
por: Tofanelli, Sergio, et al.
Publicado: (2014)

A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services
por: Peacock, S, et al.
Publicado: (2006)

Molecular variants of the ATM gene in Hodgkin's disease in children
por: Liberzon, E, et al.
Publicado: (2004)

Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper
por: Cousens, Nicole E, et al.
Publicado: (2021)

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer
por: Bernstein, J L, et al.
Publicado: (2003)

Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours
por: Reiman, A, et al.
Publicado: (2011)

In Search of the jüdische Typus: A Proposed Benchmark to Test the Genetic Basis of Jewishness Challenges Notions of “Jewish Biomarkers”
por: Elhaik, Eran
Publicado: (2016)

Genetic markers cannot determine Jewish descent
por: Falk, Raphael
Publicado: (2015)

Editorial: Population Genetics of Worldwide Jewish People
por: Elhaik, Eran
Publicado: (2017)

Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
por: Anderson, E, et al.
Publicado: (2008)

Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade
por: Ding, S L, et al.
Publicado: (2004)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

The genetic risk of gestational diabetes in South Asian women
por: Lamri, Amel, et al.
Publicado: (2022)

Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
por: Oder, Daniel, et al.
Publicado: (2016)

Haplotype architecture of the Alzheimer's risk in the APOE region via co‐skewness
por: Kulminski, Alexander M., et al.
Publicado: (2020)

Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico
por: Díaz-Velásquez, Clara Estela, et al.
Publicado: (2023)

Association of the Lactase Persistence Haplotype Block With Disease Risk in Populations of European Descent
por: Joslin, Shannon E. K., et al.
Publicado: (2020)

Mitochondrial dysfunction and risk of cancer
por: Lund, M, et al.
Publicado: (2015)

Interactions between genes involved in the antioxidant defence system and breast cancer risk
por: Oestergaard, M Z, et al.
Publicado: (2006)

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer
por: Julin, B, et al.
Publicado: (2015)

Combined effect of low-penetrant SNPs on breast cancer risk
por: Harlid, S, et al.
Publicado: (2012)

Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk
por: Webb, E, et al.
Publicado: (2008)

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women
por: Sidon, L, et al.
Publicado: (2012)

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
por: Stevens, K N, et al.
Publicado: (2011)

Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk
por: Gsur, A, et al.
Publicado: (2003)

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
por: Moon, D H, et al.
Publicado: (2013)

The TERT variant rs2736100 is associated with colorectal cancer risk
por: Kinnersley, B, et al.
Publicado: (2012)

Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer
por: Ponz de Leon, M, et al.
Publicado: (2004)

Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer
por: Overbeek, L I H, et al.
Publicado: (2007)

Extended Y chromosome haplotypes resolve multiple and unique lineages of the Jewish priesthood
por: Hammer, Michael F., et al.
Publicado: (2009)

A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants
por: Theodoratou, E, et al.
Publicado: (2010)

Familial risks in nervous system tumours: joint Nordic study
por: Hemminki, K, et al.
Publicado: (2010)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

Genetic variation in XRCC1, sun exposure, and risk of skin cancer
por: Han, J, et al.
Publicado: (2004)

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
por: Cox, D G, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_rfl5kpn5tvu8uf0os09t5jj58i